Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctors watch and learn: new study tracks endoscopy for pancreatic disease diagnosis

NCT ID NCT07418164

Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

This study will watch how doctors use a special camera (endoscopic ultrasound) to diagnose suspected pancreatic or bile duct diseases in 2500 adults across Lombardy, Italy. The goal is to see how accurate the procedure is, how safe it is, and how quickly patients get a final diagnosis and start treatment. No extra tests or treatments are given—just routine care is observed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All consecutive patients referred to participating Pancreas Unit Hub centers for EUS evaluation of suspected biliopancreatic or periampullary neoplastic disease, who meet eligibility criteria and provide informed consent.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years) * Clinical, biochemical, and/or imaging suspicion of pancreatic neoplasia (adenocarcinoma, neuroendocrine tumors, cystic neoplasms requiring endoscopic, surgical, or oncological treatment) or periampullary neoplasia (distal bile duct, ampulla, duodenum) * Candidate for EUS according to standard clinical practice * Ability to understand and sign informed consent Exclusion Criteria: * Age \<18 years * Pregnancy or breastfeeding * Conditions other than those defined in the inclusion criteria * Inability to provide informed consent * Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biliopancreatic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cystic tumor of the pancreas distal biliary tract carcinoma malignant pancreatic neoplasm pancreatic ductal adenocarcinoma pancreatic neoplasm pancreatic neuroendocrine tumor periampullary adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biliopancreatic diseases Pancreatic cancer Periampullary neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy

  • ASST Mantova - P.O. Carlo Poma Mantova

    Mantua, Italy

  • ASST Ovest Milanese - P.O. Legnano

    Legnano, Italy

  • ASST Papa Giovanni XXIII - P.O. Papa Giovanni XXIII Bergamo

    Bergamo, Italy

  • ASST Santi Paolo e Carlo - Milano

    Milan, Italy

  • ASST Sette Laghi - Ospedale di Circolo e Fond. Macchi Varese

    Varese, Italy

  • ASST Spedali Civili di Brescia - P.O. Spedali Civili Brescia

    Brescia, Italy

  • ASST di Cremona - P.O. Cremona

    Cremona, Italy

  • Casa di Cura Poliambulanza di Brescia

    Brescia, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori Milano

    Milan, Italy

  • Fondazione IRCCS Policlinico San Matteo Pavia

    Pavia, Italy

  • Fondazione IRCCS San Gerardo dei Tintori - Monza

    Monza, Italy

  • IRCCS Istituto Clinico Humanitas Milano

    Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.